Mexico / US Vaccine Tourism; CanSino Stepping Up; AMLO Calls for UN Intervention
The latest from Mexico’s fight against COVID-19, including news of vaccine tourism into the US, how China’s…
Patrick Burton |
Editor
Patrick is an editor at PharmaBoardroom, writing and editing stories on all things healthcare and the life sciences. The holder of a Master's Degree in International Relations, Patrick has contributed to over 40 country reports and is a fluent Mandarin speaker.
Articles: Patrick Burton
Asia-Pacific / HSA: A Regulatory Gold Standard for the Region
As the most important pharma hub in its region, and one of the most important globally, many companies look to…
Saudi Arabia / 5 Things to Know
A rundown of five things to know about the USD 8.2 billion Saudi pharma market, including the impact of ‘Vision…
APAC / Medtech's Post-COVID Paradigm
At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech market and, with a CAGR of nine…
MEA / Pfizer’s Saudi Transformation; Urgent Call for Arab Import Reform; Hikma & Tabuk Deals
The latest news from Middle East & North African pharma, including Pfizer’s transformation of its Saudi…
Russia / $7.4 bln for Healthcare Modernisation; Generics Push; Sputnik Vaccine Successes
The latest news from Russian pharma and healthcare including a big funding injection for primary care up to 2025,…
The Long Read / Norway: Unlocking Potential
Equality has long been a deeply held ideal in Norway, where the concept of allemannsretten – the legal right to…
Switzerland / Building a Health Data Ecosystem
Although Switzerland is ahead of many of its competitors in Europe on levels of healthcare innovation, one…
Talent / Biogen's Swiss Head on Benefits of Diverse Experience & Building an Entrepreneurial Team
A trained physician with several years of practice under her belt, Katharina Gasser then moved into clinical…
Biosimilars / Alvotech's Four Traits for Success
Alvotech – the biosimilars arm of Icelandic-headquartered generics player Alvogen – is positioning itself for…
India / 200% Pharma Sector Budget Boost; 3x Industry Growth in Next Decade; Pfizer Vaccine Rebuffed
The latest news from Indian pharma, including a 200 percent boost for the country’s pharmaceutical industry in…
Talent / Pharma Country Managers: The COVID Generation
While 2020 may have seemed like the year the world stood still for many, the pharma industry went into overdrive,…